Loading
全科 Stock: price and insider trades · Taiwan
TW·Mcap NT$11.7B
全科: what insiders have been doing
Only a handful of insider records exist for 全科, the last one from 14 October 2026, too few to describe a trend. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 10,838 of 24,148 companies
54.1
score / 100
Value70
Quality38
FCF yld38%
Earn yld6.1%
EV/EBITDA13.1x
ROE27%
Gross mgn5.2%
Net mgn1.5%
Debt/EBITDA4.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
NT$47
Analyst consensus
Income statement
RevenueNT$47.4B
Gross profitNT$2.5B5% margin
EBITDANT$1.3B3% margin
Net incomeNT$708.2M2.4% margin
Valuation
PER (trailing)8.3x
P/Book2.1x
Beta0.69
Balance sheet & cash
Market capNT$11.7B
Total debtNT$5.5B
Free Cash FlowNT$4.5B
Debt / Equity95%
Profitability & ownership
ROE27.1%
ROA5.2%
% insiders15.5%
% institutions5.8%
Last declaration on 14 October 2026
About 全科
全科 is a company listed on the XTAI market, specializing in various financial services. It provides solutions tailored to the needs of its clients in the financial sector.